BIO-TECHNE CORP Achieves High Rating with Growth Model

BIO-TECHNE CORP excels with a 77% rating in the P/B Growth Investor model. This positive assessment indicates potential interest for investors. Market analysts recognize favorable fundamentals that could drive stock prices upwards.

Date: 31-01-2025

AI Rating: 7

Earnings Per Share (EPS) No information on EPS is provided in the report. Revenue Growth No explicit figures indicating revenue growth are mentioned, however, the overall positive rating suggests potential for upward momentum. Net Income The report does not detail net income metrics. Profit Margins Profit margins are not specified in the text, limiting evaluation on this metric. Free Cash Flow (FCF) There is no mention of free cash flow, which leaves a gap in understanding liquidity. Return on Equity (ROE) No data regarding return on equity is included. Overall, the stock's rating of 77% indicates it meets a significant number of positive criteria, especially with its strong scores for book-to-market ratio and return on assets. The presence of several 'pass' indicators demonstrates the stock's solid fundamentals. However, failure in 'Advertising to Assets' and 'Research and Development to Assets' signals areas that could hinder future growth potential. The high rating could attract investor interest, potentially leading to higher stock prices. When evaluating strategies, a score of 80% or more is typically seen as a bullish signal, making TECHs current standing slightly below this benchmark intriguing for growth-focused investors.

Stocks: TECH